We are live on
!
Find out more
CCM
Cupps Capital Management Portfolio holdings
AUM
$231M
1-Year Est. Return
49.73%
This Fund
S&P 500
This Quarter
Est. Return
+19.18%
1 Year Est. Return
+49.73%
3 Year Est. Return
+212.7%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$231M
AUM Growth
-$156M
(-40%)
Cap. Flow
-$194M
Cap. Flow
% of AUM
-83.99%
Top 10 Holdings %
Top 10 Hldgs %
24.21%
Holding
206
New
45
Increased
20
Reduced
112
Closed
29
Top Buys
| 1 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$2.5M |
| 2 |
Glaukos
GKOS
|
+$2.17M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
+$1.61M |
| 4 |
CAVM
Cavium, Inc.
CAVM
|
+$1.52M |
| 5 |
BLUE
bluebird bio
BLUE
|
+$1.51M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$9.12M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
+$8.36M |
| 3 |
Amazon
AMZN
|
+$7.51M |
| 4 |
Burlington
BURL
|
+$6.63M |
| 5 |
Texas Roadhouse
TXRH
|
+$5.36M |
Sector Composition
| 1 | Technology | 39.39% |
| 2 | Healthcare | 24.2% |
| 3 | Consumer Discretionary | 10.03% |
| 4 | Industrials | 9.46% |
| 5 | Real Estate | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYBR
26
DELISTED
CyberArk
CYBR
| $2.28M | 0.99% |
46,065
-36,471
| -44% | -$1.94M |
|
27
Neurocrine Biosciences
NBIX
$17.2B
| $2.22M | 0.96% |
43,902
+5
| +0% | +$249 |
|
|
COHR
28
DELISTED
Coherent Inc
COHR
| $2.21M | 0.96% |
20,007
+52
| +0.3% | +$5.39K |
|
29
Palo Alto Networks
PANW
$289B
| $2.19M | 0.95% |
82,602
+26,682
| +48% | +$608K |
|
|
ORBK
30
DELISTED
Orbotech Ltd
ORBK
| $2.14M | 0.93% |
72,406
-21,160
| -23% | -$600K |
|
31
Penumbra
PEN
$12.6B
| $2.12M | 0.92% |
27,892
-10,092
| -27% | -$696K |
|
32
Albemarle
ALB
$14.1B
| $2.11M | 0.91% |
24,693
-24,980
| -50% | -$2.06M |
|
33
Granite Construction
GVA
$5.5B
| $2.09M | 0.91% |
42,116
-24,314
| -37% | -$1.18M |
|
34
NVIDIA
NVDA
$5.02T
| $2.08M | 0.9% |
1,212,920
-120,280
| -9% | -$178K |
|
35
Littelfuse
LFUS
$10.2B
| $2.01M | 0.87% |
15,576
-1,399
| -8% | -$171K |
|
36
Universal Display
OLED
$3.73B
| $1.99M | 0.86% |
35,924
-62,644
| -64% | -$3.97M |
|
37
CoStar Group
CSGP
$12.4B
| $1.96M | 0.85% |
90,740
-123,530
| -58% | -$2.63M |
|
38
Middleby
MIDD
$6.25B
| $1.86M | 0.8% |
15,019
-1,435
| -9% | -$176K |
|
|
BLUE
39
DELISTED
bluebird bio
BLUE
| $1.82M | 0.79% |
+2,078
| New | +$1.51M |
|
|
SYNH
40
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.82M | 0.79% |
40,862
-23,008
| -36% | -$998K |
|
41
Domino's
DPZ
$11B
| $1.77M | 0.77% |
11,692
-11,928
| -50% | -$1.74M |
|
|
LOGM
42
DELISTED
LogMein, Inc.
LOGM
| $1.77M | 0.77% |
19,624
-12,353
| -39% | -$989K |
|
|
ZLTQ
43
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $1.77M | 0.77% |
45,186
+20,761
| +85% | +$741K |
|
44
Coherent
COHR
$54.2B
| $1.77M | 0.77% |
72,677
-5,973
| -8% | -$126K |
|
|
TSRO
45
DELISTED
TESARO, Inc.
TSRO
| $1.73M | 0.75% |
+17,209
| New | +$1.61M |
|
46
CEVA Inc
CEVA
$1.07B
| $1.72M | 0.74% |
48,955
+46,380
| +1,801% | +$1.44M |
|
|
CALY
47
Callaway Golf Company
CALY
$3.5B
| $1.7M | 0.74% |
146,840
-48,743
| -25% | -$544K |
|
48
Bright Horizons
BFAM
$4B
| $1.7M | 0.74% |
25,445
-14,710
| -37% | -$991K |
|
49
Constellation Brands
STZ
$23.2B
| $1.7M | 0.73% |
10,195
-16,131
| -61% | -$2.66M |
|
50
Corpay
CPAY
$24.3B
| $1.7M | 0.73% |
9,772
+1,622
| +20% | +$260K |
|
Similar funds
SA
WIM
EDRE
RIG
VBCP
TI
ZBI
MI
Cupps Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Cupps Capital Management held 206 positions worth $231M, down 40% from $387M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Cupps Capital Management withdrew a net $194M in Q3 2016, closing 29 positions and reducing 112 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $3.68M position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Cupps Capital Management opened a new position in Medidata Solutions, Inc. worth $2.63M.
- Cupps Capital Management's largest Q3 2016 buy was Medidata Solutions, Inc.: 47,254 shares worth $2.63M.
- Cupps Capital Management added most to Cavium, Inc. in Q3 2016, an estimated $1.52M increase.
- Cupps Capital Management's biggest Q3 2016 reduction was Abiomed Inc, cutting an estimated $9.12M.
- Cupps Capital Management fully exited Bristol-Myers Squibb in Q3 2016, selling an estimated $3.68M.
- Cupps Capital Management's ten largest holdings make up 24% of its $231M portfolio in Q3 2016.
- Cupps Capital Management opened 45 new positions and closed 29 in Q3 2016.
- Cupps Capital Management's portfolio value fell 40% quarter-over-quarter to $231M.
Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.